Category : Healthcare and Pharmaceuticals | Published at : November-2020 | Delivery Format : PDF | Status: Published | Pages : 190
The market for brain injuries treatment is expected to grow at a CAGR of around 5.4% from 2020 to 2027 and expected to reach the market value of around US$ 187.6 Bn by 2027.
Brain injury is caused due to falls, road accidents, tumors, and stroke. This brain injury results in a change to the brain's neuronal activity that affects the physical reliability, metabolic activity, or functional ability of nerve cells in the brain. Brain injury causes an alteration in the brain function, or other evidence of brain pathology, caused by an external force. There are two types of brain injury including traumatic and non-traumatic brain injury. Traumatic brain injury is caused by fall, assaults, motor vehicle accidents, sports/recreation injuries, abusive head trauma (shaken baby syndrome), gunshot wounds, workplace injuries, child abuse, domestic violence, military actions (blast injury). Whereas non-traumatic brain injury is caused by stroke (haemorrhage, blood clot), infectious disease, meningitis, encephalitis, seizure, electric shock, tumors, metabolic disorders, neurotoxic poisoning (carbon monoxide, lead exposure), lack of oxygen (drowning, choking, hypoxic/anoxic injury), and drug overdose.
Market Dynamics
Rising injuries caused to the brain across the globe result in a high incidence of brain disorder that are driving the market growth. The increasing number of accidents caused by vehicles is supporting market growth. Around 52,000 people die from traumatic brain injuries every year globally, which is commonly caused by accidents, violent assaults, blunts force trauma, and sports injuries. The availability of a range of breakthrough diagnostics, drugs, and novel treatment procedures in the market is further bolstering market growth. In addition, ongoing research and development activities are further projected to create potential opportunities throughout the forecast timeframe from 2020 to 2027.
On the other side, unawareness about the diseases and its treatment in some economies, lack of skilled professionals in developing and underdeveloped economies is anticipated to limit the growth to an extent throughout the forecast period.
Segment Instance
North America is leading the market with maximum revenue share
In 2019, North America accounted for the maximum share in terms of revenue in the global brain injuries treatment market. The well-established healthcare infrastructure and availability of advanced procedures are boosting the regional market value. The rising rate of traumatic brain injuries (TBI) patients, hospitalizations, and deaths occurring due to TBI is further bolstering the market growth. The US accounted for the maximum revenue share in the global market.
Asia Pacific is projected to experience fastest growth over the forecast period from 2020 to 2027
Asia Pacific region is expected to grow at faster rate during the forecast timeframe. The rapidly developing economies of the region including India and China are bolstering the regional market value. The increasing investment by the major players in the region in order to take advantage of available opportunities is further propelling the regional market value. The increasing motor vehicle accidents, sports/recreation injuries, domestic violence, and military actions are some of the other factors bolstering the regional market value.
Key Market Player
The players profiled in the report include Amarantus Bioscience Holdings, Inc., Banyan Biomarkers, Inc., BioDirection, Medicortex Finland Oy, Neural Analytics, Inc., Neuren Pharmaceuticals, Oculogica, QuesGen Systems, Inc., Stemedica Cell Technologies, Inc., Teva Pharmaceutical Industries Ltd., Vasopharm, Zimmer Biomet, and others. The major market players were involved in mergers and acquisitions, partnerships & collaborations, and new Source development for the expansion of market share (%).
Market Segmentation
Market By Treatment
Immediate Emergency Care
Medications
Surgery
Market By Route of Administration
Parenteral
Oral
Market By Patient Age
Children
Teenager
Elder
Market By Gender
Male
Female
Market By Cause of Injury
Falls
Motor Vehicle Traffic
Sports
Others
Market By End Users
Hospitals
Neurology Clinics
Independent Pharmacies
Others
Market By Geography
North America
- U.S.
- Canada
Europe
- UK
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Frequently Asked Questions
The market for brain injuries treatment is expected to reach a market value of around US$ 187.6 Bn by 2027.
The brain injuries treatment market is expected to grow at a CAGR of around 5.4% from 2020 to 2027.
Rising incidences and injuries caused to the brain, high prevalence of target disorders, increasing number of accidents caused by the vehicles, availability of range of breakthrough diagnostics, drugs, and novel treatment procedures in the market are some of the factors driving the market growth.
AMARANTUS BIOSCIENCE HOLDINGS, INC., BANYAN BIOMARKERS, INC., BioDirection, Medicortex Finland Oy, Neural Analytics, Inc., Neuren Pharmaceuticals, Oculogica, QuesGen Systems, Inc., Stemedica Cell Technologies, Inc., Teva Pharmaceutical Industries Ltd., VASOPHARM, Zimmer Biomet, and other are the prominent players in the brain injuries treatment market.
North America held the highest market share in the brain injuries treatment market
Asia Pacific is expected to be the fastest growing market over the forecast period
Immediate Emergency Care segment is the leading segment by treatment in the Brain Injuries Treatment Market
